Surcel H M

Top coauthors of Surcel H M

Saikku P (18 papers)

Ilonen J (17 papers)

Bloigu A (11 papers)

Syrjälä H (10 papers)

Leinonen M (10 papers)

List of Surcel H M publications


Schock H, Lundin E, Vääräsmäki M, Grankvist K, Fry A, et al. 2014. "Anti-Mullerian hormone and risk of invasive serous ovarian cancer." Cancer causes & control : CCC 25 (5) doi:10.1007/s10552-014-0363-9


Toriola A T, Grankvist K, Agborsangaya C B, Lukanova A, Lehtinen M, Surcel H M 2011. "Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study." Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 22 (8) doi:10.1093/annonc/mdq694


Rainio A, Hautala N, Pelkonen O, Palosaari T, Heikkinen J, et al. 2007. "Risk of retinal microembolism after off-pump and on-pump coronary artery bypass surgery." The Journal of cardiovascular surgery 48 (6) doi:


Mosorin M, Juvonen J, Biancari F, Satta J, Surcel H M, et al. 2001. "Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study." Journal of vascular surgery 34 (4) doi:10.1067/mva.2001.117891
Kallio R, Surcel H M, Bloigu A, Syrjälä H 2001. "Balance between interleukin-10 and interleukin-12 in adult cancer patients with or without infections." European journal of cancer (Oxford, England : 1990) 37 (7) doi:
Wuorimaa T, Käyhty H, Eskola J, Bloigu A, Leroy O, Surcel H M 2001. "Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine." Scandinavian journal of immunology 53 (4) doi:
Kallio R, Surcel H M, Bloigu A, Syrjälä H 2001. "Admission neopterin and interleukin 12 concentrations in identifying infections in adult cancer patients." Cytokine 13 (6) doi:10.1006/cyto.2000.0840
Kallio R, Bloigu A, Surcel H M, Syrjälä H 2001. "C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 9 (2) doi:
Kinnunen A, Paavonen J, Surcel H M 2001. "Heat shock protein 60 specific T-cell response in chlamydial infections." Scandinavian journal of immunology 54 (1-2) doi:


Halme S, Latvala J, Karttunen R, Palatsi I, Saikku P, Surcel H M 2000. "Cell-mediated immune response during primary Chlamydia pneumoniae infection." Infection and immunity 68 (12) doi:
Kinnunen A, Molander P, Laurila A, Rantala I, Morrison R, et al. 2000. "Chlamydia trachomatis reactive T lymphocytes from upper genital tract tissue specimens." Human reproduction (Oxford, England) 15 (7) doi:
Kallio R, Surcel H M, Bloigu A, Syrjälä H 2000. "C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients." European journal of cancer (Oxford, England : 1990) 36 (7) doi:
Mosorin M, Surcel H M, Laurila A, Lehtinen M, Karttunen R, et al. 2000. "Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery." Arteriosclerosis, thrombosis, and vascular biology 20 (4) doi:
Airenne S, Surcel H M, Bloigu A, Laitinen K, Saikku P, Laurila A 2000. "The resistance of human monocyte-derived macrophages to Chlamydia pneumoniae infection is enhanced by interferon-gamma." APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 108 (2) doi:


Halme S, Juvonen T, Laurila A, Juvonen J, Mosorin M, et al. 1999. "Chlamydia pneumoniae reactive T lymphocytes in the walls of abdominal aortic aneurysms." European journal of clinical investigation 29 (6) doi:
Alakärppä H, Surcel H M, Laitinen K, Juvonen T, Saikku P, Laurila A 1999. "Detection of Chlamydia pneumoniae by colorimetric in situ hybridization." APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 107 (4) doi:
Airenne S, Surcel H M, Alakärppä H, Laitinen K, Paavonen J, et al. 1999. "Chlamydia pneumoniae infection in human monocytes." Infection and immunity 67 (3) doi:


Halme S, von Hertzen L, Bloigu A, Kaprio J, Koskenvuo M, et al. 1998. "Chlamydia pneumoniae-specific cell-mediated and humoral immunity in healthy people." Scandinavian journal of immunology 47 (5) doi:
von Hertzen L, Surcel H M, Kaprio J, Koskenvuo M, Bloigu A, et al. 1998. "Immune responses to Chlamydia pneumoniae in twins in relation to gender and smoking." Journal of medical microbiology 47 (5) doi:
Anttila T, Leinonen M, Surcel H M, Von Hertzen L, Bloigu A, et al. 1998. "IgG subclass-specific antibodies in Chlamydia pneumoniae infections." Scandinavian journal of infectious diseases 30 (4) doi:


Juvonen J, Surcel H M, Satta J, Teppo A M, Bloigu A, et al. 1997. "Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm." Arteriosclerosis, thrombosis, and vascular biology 17 (11) doi:
Halme S, Syrjälä H, Bloigu A, Saikku P, Leinonen M, et al. 1997. "Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease." European heart journal 18 (7) doi:
Von Hertzen L, Alakärppä H, Koskinen R, Liippo K, Surcel H M, et al. 1997. "Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease." Epidemiology and infection 118 (2) doi:
Halme S, Saikku P, Surcel H M 1997. "Characterization of Chlamydia pneumoniae antigens using human T cell clones." Scandinavian journal of immunology 45 (4) doi:
Juvonen J, Laurila A, Juvonen T, Aläkarppä H, Surcel H M, et al. 1997. "Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves." Journal of the American College of Cardiology 29 (5) doi:
Juvonen J, Juvonen T, Laurila A, Alakärppä H, Lounatmaa K, et al. 1997. "Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms." Journal of vascular surgery 25 (3) doi:
Halme S, Surcel H M 1997. "Cell mediated immunity to Chlamydia pneumoniae." Scandinavian journal of infectious diseases. Supplementum 104 doi:


Syrjänen K, Nurmi T, Mäntyjärvi R, Ilonen J, Syrjänen S, et al. 1996. "HLA types in women with cervical human papillomavirus (HPV) lesions prospectively followed up for 10 years." Cytopathology : official journal of the British Society for Clinical Cytology 7 (2) doi:


von Hertzen L, Leinonen M, Surcel H M, Karjalainen J, Saikku P 1995. "Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae." Clinical and diagnostic laboratory immunology 2 (4) doi:


Surcel H M, Troye-Blomberg M, Paulie S, Andersson G, Moreno C, et al. 1994. "Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens." Immunology 81 (2) doi:


Harris D P, Vordermeier H M, Friscia G, Román E, Surcel H M, et al. 1993. "Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T cells." Journal of immunology (Baltimore, Md. : 1950) 150 (11) doi:
Surcel H M, Syrjälä H, Leinonen M, Saikku P, Herva E 1993. "Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro." Infection and immunity 61 (5) doi:


Vordermeier H M, Harris D P, Friscia G, Román E, Surcel H M, et al. 1992. "T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease." European journal of immunology 22 (10) doi:10.1002/eji.1830221024


Ilonen J, Surcel H M, Käär M L 1991. "Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes." Clinical and experimental immunology 85 (2) doi:
Ryhänen P, Surcel H M, Ilonen J 1991. "Decreased expression of class II major histocompatibility complex (MHC) molecules on monocytes is found in open-heart surgery related immunosuppression." Acta anaesthesiologica Scandinavica 35 (5) doi:
Surcel H M, Syrjälä H, Karttunen R, Tapaninaho S, Herva E 1991. "Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia." Infection and immunity 59 (6) doi:
Karttunen R, Surcel H M, Andersson G, Ekre H P, Herva E 1991. "Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings." Journal of clinical microbiology 29 (4) doi:
Syrjälä H, Surcel H M, Ilonen J 1991. "Low CD4/CD8 T lymphocyte ratio in acute myocardial infarction." Clinical and experimental immunology 83 (2) doi:
Surcel H M, Tapaninaho S, Herva E 1991. "Cytotoxic CD4+ T cells specific for Francisella tularensis." Clinical and experimental immunology 83 (1) doi:


Surcel H M 1990. "Diversity of Francisella tularensis antigens recognized by human T lymphocytes." Infection and immunity 58 (8) doi:
Jokinen I, Poikonen K, Möttönen T, Hannonen P, Oka M, et al. 1990. "Analysis of impaired in vitro immunoglobulin synthesis in rheumatoid arthritis." Annals of the rheumatic diseases 49 (7) doi:
Ilonen J, Surcel H M, Jägerroos H, Nurmi T, Reunanen M 1990. "T-lymphocyte subsets defined by double immunofluorescence in multiple sclerosis." Acta neurologica Scandinavica 81 (2) doi:


Surcel H M, Sarvas M, Helander I M, Herva E 1989. "Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals." Microbial pathogenesis 7 (6) doi:
Surcel H M, Ilonen J, Poikonen K, Herva E 1989. "Francisella tularensis-specific T-cell clones are human leukocyte antigen class II restricted, secrete interleukin-2 and gamma interferon, and induce immunoglobulin production." Infection and immunity 57 (9) doi:
Karjalainen J, Salmela P, Ilonen J, Surcel H M, Knip M 1989. "A comparison of childhood and adult type I diabetes mellitus." The New England journal of medicine 320 (14) doi:10.1056/NEJM198904063201401


Hyöty H, Leinikki P, Reunanen A, Ilonen J, Surcel H M, et al. 1988. "Mumps infections in the etiology of type 1 (insulin-dependent) diabetes." Diabetes research (Edinburgh, Scotland) 9 (3) doi:
Ilonen J, Surcel H M, Partanen J, Koskimies S, Knip M, Käär M L 1988. "Extended HLA haplotypes in families with insulin-dependent diabetes mellitus in northern Finland." Tissue antigens 32 (3) doi:
Surcel H M, Ilonen J, Käär M L, Hyöty H, Leinikki P 1988. "Infection by multiple viruses and lymphocyte abnormalities at the diagnosis of diabetes." Acta paediatrica Scandinavica 77 (3) doi:


Karttunen R, Andersson G, Ekre H P, Juutinen K, Surcel H M, et al. 1987. "Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination." Journal of clinical microbiology 25 (6) doi:
Surcel H M, Karttunen R, Ilonen J, Käär M L 1987. "Lymphocyte responsiveness and interleukin 2 production in type 1 (insulin-dependent) diabetes mellitus." Journal of clinical & laboratory immunology 22 (4) doi:
Ryhänen P, Ilonen J, Surcel H M, Nurmi T, Poikonen K, et al. 1987. "Characterization of in vivo activated lymphocytes found in the peripheral blood of patients undergoing cardiac operation." The Journal of thoracic and cardiovascular surgery 93 (1) doi:


Hyöty H, Räsänen L, Lehto M, Tanhuanpää P, Eerola A, et al. 1986. "Cell-mediated and humoral immunity to mumps virus antigen." Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology 94 (5) doi:


Ilonen J, Surcel H M, Mustonen A, Käär M L, Akerblom H K 1984. "Lymphocyte subpopulations at the onset of type 1 (insulin-dependent) diabetes." Diabetologia 27 Suppl doi:
Mustonen A, Ilonen J, Surcel H M, Akerblom H K 1984. "A 'new' DR4 associated D specificity 'JA' in type 1 (insulin-dependent) diabetes: A9, Bw16, DJA, DR4 haplotype." Diabetologia 27 Suppl doi:
Karttunen R, Nurmi T, Ilonen J, Surcel H M 1984. "Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets." Clinical and experimental immunology 55 (2) doi: